齐鲁晚报·齐鲁壹点 通讯员 张永滨 郭文艺 9月21日，2025中小城市高质量发展交流会召开，在最新发布的《中国中小城市高质量发展指数报告》 中，滨城区成功入围全国综合实力百强区，位列第88位。这是该区在高新区建设、中心城区品质提升、 高铁片区未来布局上精准发力、系统推进的必然结果。 高新区崛起：打造产业强区的"核心引擎" 在发展经济的同时，滨城区始终秉持"人民城市为人民"的理念，投入巨资实施城市更新行动，让发展成 果更多更公平地惠及全体市民。 2023年，滨城区启动了建区以来最大规模的城市品质提升工程，计划三年投入180亿元，实施126个城市 更新项目。实施城中村改造，交付完成安置区16个，交付安置房15735套，数量位列全市第1位，实施老 旧小区改造工程，圆满完成在册老旧小区既定改造任务。打通"断头路"是市民感受最直接的变革。近年 来，盛华路等"四路三桥"建成通车，城区13条"断头路"全面打通。实施秦台河综合改造提升工程，清淤 底泥13万方，新建地下排水管网92公里，清淤管网586公里，彻底疏通了城市的"毛细血管"，"路通了， 心顺了"成为市民的普遍心声。 同时，滨城区高标准提升7个农贸市场，整治30条背 ...

Group 1 - The company, Baolingbao Biotech Co., Ltd., established in 1997, specializes in the production of functional sugar products using corn as raw material and has become a leader in China's functional sugar industry [1] - The company has a comprehensive production capacity of over 1 million tons, with 16 production lines and a workforce of approximately 1,400 employees [1] - Baolingbao is recognized as a national high-tech enterprise and has been the first in China to achieve industrial-scale production of oligosaccharides [1] Group 2 - The company has implemented a rigorous grain safety management system to ensure the quality and safety of corn supply, with a planned storage of 320,000 tons of corn in 2024, averaging 1,000 tons per day [2] - The procurement process is transparent, utilizing mobile apps and WeChat mini-programs to publish purchasing information and ensure timely payment to farmers [2] - The company monitors market prices dynamically to ensure reasonable procurement prices and protect farmers' interests [2] Group 3 - The company has increased investment in storage facilities, with 13 grain storage units and a total storage capacity of 80,000 tons [3] - New storage facilities are equipped with intelligent systems for real-time monitoring of temperature, humidity, and grain conditions, enhancing operational efficiency [3] - Upgrades to existing storage facilities are ongoing to improve automation and smart technology [3] Group 4 - The company focuses on innovation in deep processing of corn, extending the value chain from starch to functional sugars and high-value products [4] - Recent product developments include erythritol, allulose, and DHA, contributing to significant value addition and economic benefits [4] - The company's efforts in deep processing not only enhance its economic performance but also support local agricultural development and food security [4]

Group 1 - Global Printing announced that shareholder Hong Kong Yuanshi International Co., Ltd. plans to reduce its stake by up to 3.2004 million shares, accounting for 1% of the total share capital, due to personal funding needs [1] - Sunflower intends to acquire 100% equity of Xi Pu Materials and 40% equity of Zhejiang Beid Pharmaceutical through a combination of share issuance and cash payment, with stock resuming trading on September 22, 2025 [1][2] - Crown Zhong Ecology is planning a change in control, leading to a temporary suspension of its stock and convertible bonds due to significant uncertainties [2] Group 2 - China Oil Engineering's wholly-owned subsidiary signed a $513 million EPC contract for an LNG pipeline project in the UAE, covering approximately 180.5 kilometers of natural gas pipeline with a 36-month construction period [3] - Shanxi Fenjiu announced that shareholder Huachuang Xinrui (Hong Kong) Co., Ltd. plans to reduce its stake by up to 16.2006 million shares, representing no more than 1.33% of the total share capital [4] - Brother Technology's subsidiary received a drug registration certificate for Iopamidol injection, which is included in the national medical insurance catalog [5] Group 3 - Lin Yang Energy is expected to win a bid for a metering equipment project from the State Grid, with an estimated total bid amount of approximately 142 million yuan [6] - Huahai Chengke received approval from the China Securities Regulatory Commission for issuing shares and convertible bonds to purchase assets and raise no more than 800 million yuan in matching funds [8] - Jindi Co. signed a framework agreement to acquire controlling interest in Unico Precision, which specializes in manufacturing gears and automotive parts [10] Group 4 - Ruifeng High Materials announced that its major shareholder plans to reduce its stake by up to 2.4 million shares, accounting for 0.9584% of the total share capital [12] - Changliang Technology's director plans to reduce his stake by 1.05 million shares, representing 0.129% of the total share capital [14] - Zhongjing Food's director plans to reduce his stake by up to 150,000 shares, accounting for 0.10% of the total share capital [16] Group 5 - Haitai Technology announced that two shareholders plan to reduce their stakes by a total of up to 2.53% of the total share capital [18] - Zhenlei Technology's chairman is under detention but the company states that control has not changed and operations remain normal [20] - Huakang Co. plans to distribute a cash dividend of 0.2 yuan per share, totaling approximately 60.61 million yuan [19]

Summary of the Sorbitol Industry Conference Call Industry Overview - The sorbitol industry has a total production capacity of approximately 120,000 tons, with Huakang and Yuxin accounting for over 50% of the market share, and Futian ranking third. [1][4] - The industry operates at a utilization rate of 65%-70%, which is lower than during the pandemic due to export and tariff impacts. [1][11] - Demand for sorbitol is diversifying, with significant growth in dairy products and beverages, while the chewing gum market is declining due to health and environmental concerns. [1][5] Key Players and Market Dynamics - Huakang has a cost advantage in raw materials, with suppliers like Sichuan Yuanhua and Gaomi factories. The merger with Yuxin is expected to enhance market competitiveness. [1][6] - Global sorbitol production is primarily concentrated in China, with overseas companies like DuPont and Danisco operating on a smaller scale. [1][8] - Sorbitol and maltitol can be produced interchangeably, but only Huakang and Futian have this capability. [1][10] Pricing and Future Trends - Current sorbitol prices are around 17,000 RMB/ton, at a historical low, influenced by market competition and reduced exports. [1][13] - Prices are expected to rebound in 2026 due to potential government intervention and rising prices of high-intensity sweeteners. [1][14] Demand Growth and Applications - The sorbitol industry has been growing at a rate of 10% annually since 2020, with significant increases in sugar-free candy and baking products. [3][5] - Major clients in the beverage sector, such as Yuanqi Forest and Nongfu Spring, are driving demand growth at rates of 25%-30% annually. [5] - The candy industry is seeing a shift, with sorbitol now constituting 85%-90% of the ingredients used, indicating strong market demand. [20] Customer Structure and Contracting - The customer structure in the sorbitol industry is somewhat concentrated, with large clients making up about 40% of the market. Annual contracts are typically signed twice a year, ensuring price stability. [2][23] Supply Chain and Raw Material Impact - The supply chain is affected by raw material price fluctuations, but overall stability is maintained despite occasional short-term supply issues. [25][26] - The industry is experiencing seasonal demand fluctuations, with peak seasons for baking products around the Mid-Autumn Festival and Spring Festival. [24] Production Capacity and Future Supply - The total production capacity of sorbitol is approximately 120,000 tons, with Huakang and Yuxin holding over 60,000 tons combined. [4] - Futian is expanding its production capacity, while Tanghe Tang's expansion plans are progressing slowly. [7] Conclusion - The sorbitol industry is characterized by a strong domestic market presence, competitive pricing dynamics, and a growing demand across various sectors, particularly in health-conscious products. The future outlook suggests potential price recovery and continued growth driven by consumer trends and market consolidation.

Group 1: Industry Overview - The global trend towards "zero sugar" is reshaping consumer choices, with 75% of beverage consumers in China opting for sugar substitutes due to health concerns [1] - The global erythritol market is projected to reach approximately $910 million in 2024, with China dominating the market with a 73% share [1] - The rapid development of the sugar-reduction food industry is heavily reliant on biotechnology, particularly using corn as a raw material for natural sweeteners like erythritol [1] Group 2: Company Profile - Dongxiao Biotechnology Co., Ltd. is emerging as a significant player in China's biotechnology sector, leveraging advanced corn deep-processing technology and automated production capabilities [1] - The company has an annual corn processing capacity of 1.7 million tons, enabling a full-chain production process that includes the conversion of corn into erythritol, starch sugars, and amino acids [1] - Dongxiao has established partnerships with renowned brands such as Yuanqi Forest, Coca-Cola, Nestlé, Unilever, BASF, and Charoen Pokphand Group [2] Group 3: Technological Advancements - Dongxiao has a research team of nearly 200 members, including academicians and PhD holders, and has developed a four-tiered research and development system [2] - The company has optimized fermentation processes, reducing the fermentation cycle by 25% and increasing conversion rates by 5%, while also lowering energy consumption by 15% [2] - Dongxiao is preparing to launch the next generation of natural sweeteners, allulose, which has a sweetness level of about 70% compared to sucrose and only 10% of its calories [2] Group 4: Future Outlook - Dongxiao aims to continue expanding in the functional product sector and enhance the value chain of the health industry [3] - The company is positioned to contribute to the global health wave with its innovative approaches to "healthy sweetness" [3]

Core Insights - Erythritol, a key ingredient in the booming "zero-sugar" beverage market, is gaining attention, with Dongxiao Biological being a significant supplier for well-known companies like Yuanqi Forest [1] - Dongxiao Biological is planning to list on the New Third Board, having submitted its public transfer statement on June 30, with its application materials officially accepted [1] - The company, established in December 2004 and located in Zhucheng, Weifang City, focuses on synthetic biology manufacturing and fermentation technology, producing a range of products including animal nutrition, solid beverages, food additives, organic acids, and health sweeteners [1] Financial Performance - Dongxiao Biological's projected revenues for 2023 and 2024 are approximately 7.993 billion yuan and 7.840 billion yuan, respectively [1] - The net profits for the same periods are expected to be 298 million yuan and 578 million yuan [1] - The comprehensive gross profit margins are forecasted to be 10.33% and 13.91% for 2023 and 2024, respectively [1] Market Position - The global erythritol market is projected to reach approximately 910 million USD in 2024, with Chinese companies dominating the market with a 73% share, while Europe and the US combined account for about 22% [1] - Dongxiao Biological has established a complete value chain from raw materials to high-value products, utilizing its annual processing capacity of 1.7 million tons of corn [2] Production Efficiency - Dongxiao Biological has achieved significant breakthroughs in microbial fermentation, reducing the fermentation cycle by 25% and increasing the conversion rate by 5% compared to the industry average [3] - The company's erythritol products are supplied to major brands such as Yuanqi Forest, Coca-Cola, and Nestlé, contributing to the popularization of "zero-sugar" products [3] Future Developments - Dongxiao Biological is also focusing on the next generation of natural sweeteners, such as allulose, with a dedicated R&D team of nearly 200 members, including 5 PhDs and over 40 master's degree holders [3] - The company has established technology platforms for gene editing, high-throughput screening, and fermentation process regulation to drive innovation in biological manufacturing [3]

Group 1 - The sugar substitute market in China is expanding, with a projected market size exceeding 400 billion yuan in 2023 and expected to reach 600 billion yuan by 2025 [2] - China is the largest producer of sugar substitutes globally, accounting for 75% of the world's production [2] - The demand for sugar substitutes is driven by health considerations, with 75% of beverage consumers in China opting for sugar-free products [2] Group 2 - Erythritol has become a mainstream sugar substitute due to its safety, zero calories, and non-impact on blood sugar levels, with the global market expected to reach approximately $910 million by 2024 [3] - In 2023, China's erythritol production capacity reached 380,000 tons, exceeding global demand, leading to price declines from 40,000 yuan/ton to 9,500 yuan/ton [3] - The erythritol industry is entering a phase of capacity reduction starting in 2024 due to previous overcapacity [3][4] Group 3 - Erythritol prices have shown signs of recovery, with current prices around 10,000 yuan/ton after a brief increase to 13,000 yuan/ton [5] - Major companies like Dongxiao Biological and Sanyuan Biological are focusing on improving production efficiency and product quality in the erythritol sector [6] - Dongxiao Biological is developing deep processing products from erythritol, such as erythritol ketone, which is gaining popularity in the European and American markets [6] Group 4 - Allulose, a new generation sugar substitute, has been approved for use in China, with a sweetness level of about 70% that of sucrose and only 10% of its calories [7] - Major sugar substitute producers are increasing investments in allulose production, with Dongxiao Biological expecting to launch its first products by the end of the year [8] - The global allulose market has grown from $33 million in 2019 to $173 million in 2023, with a projected CAGR of 33.26% [9]

Core Insights - The global health food revolution is significantly linked to corn, with rising health awareness driving consumers to reduce sugar intake and opt for sugar substitutes like erythritol [1][2] - The erythritol market is projected to reach approximately $910 million in 2024, with China dominating the market at a 73% share, highlighting its central role in the global supply chain [1] - Dongxiao Biotechnology Co., Ltd. is emerging as a key player in China's biotech sector, leveraging advanced corn processing technology and automation to produce high-value products [1][2] Company Overview - Dongxiao Biotechnology operates a fully integrated value chain, converting corn into various high-value products, including starch sugars, erythritol, and amino acids, through precise fermentation and extraction processes [2] - The company has an annual corn processing capacity of 1.7 million tons, enabling it to maximize the value derived from each corn kernel [2] - The production process includes advanced membrane separation and purification techniques, resulting in erythritol with a purity of over 99.5% [2] Product Advantages - Erythritol is favored by many well-known brands due to its natural origin and safety, being the only natural sweetener recognized as having no daily intake limit by various health authorities [3] - Its unique properties, such as zero calories, non-participation in blood sugar metabolism, and high tolerance, make it suitable for a wide range of applications in food, health products, cosmetics, and pharmaceuticals [3] Technological Innovation - Dongxiao Biotechnology has invested heavily in R&D, employing a team of nearly 200 professionals, including academicians and PhDs, to drive innovation in synthetic biology and fermentation technology [4] - The company has optimized its fermentation process, reducing the fermentation cycle by 25% and increasing conversion rates by 5%, while also lowering energy consumption by 15% [5] Future Developments - The company is positioning itself for the next generation of natural sweeteners, specifically allulose, which has a sweetness level similar to sucrose but only 10% of its calories [6] - Allulose has been approved as a new food ingredient in China and is expected to be widely used in various food products, including baked goods and beverages [6] - Dongxiao Biotechnology aims to expand its product offerings in functional products, probiotics, functional amino acids, rare sugars, and biodegradable materials, enhancing its value chain in the health industry [6]

Core Insights - The global health food revolution is significantly linked to corn, with a rising demand for sugar alternatives driven by health consciousness and weight management needs [1] - The global erythritol market is projected to reach approximately $910 million in 2024, with China dominating the market with a 73% share [1] - Dongxiao Biotechnology Co., Ltd. is emerging as a key player in China's biotechnology sector, leveraging advanced corn deep processing technology and automation [1] Company Overview - Dongxiao Biotechnology operates a fully integrated value chain, converting corn into high-value products such as starch sugars, erythritol, and amino acids through precise fermentation and extraction processes [2] - The company has an annual corn processing capacity of 1.7 million tons, enabling it to produce a wide range of products, enhancing resource utilization efficiency and establishing a circular economy [2] Product Advantages - Erythritol is favored by many well-known brands due to its natural and safe profile, being the only natural sweetener recognized as having no daily intake limit by health authorities [3] - The safety of erythritol has been validated by organizations such as WHO and FDA, making it widely applicable in food, health products, cosmetics, and pharmaceuticals [3] Technological Innovation - Dongxiao Biotechnology has invested in a robust R&D team of nearly 200 members, focusing on synthetic biology and fermentation technology to enhance production efficiency [4][5] - The company has achieved a 25% reduction in fermentation cycle time and a 15% decrease in energy consumption through proprietary technologies, promoting green manufacturing practices [5] Future Developments - The company is strategically positioning itself in the next generation of natural sweeteners, specifically allulose, which has a sweetness level similar to sucrose but with significantly lower calories [6] - Dongxiao Biotechnology aims to expand its functional product offerings, including probiotics, functional amino acids, rare functional sugars, and biodegradable materials, to enhance the health industry value chain [6]

Core Insights - The global consumer trend towards reducing sugar intake is driven by increased health awareness and weight management needs, with 75% of beverage consumers in China opting for sugar substitutes [1] - The global erythritol market is projected to reach approximately $910 million in 2024, with China dominating the market with a 73% share [1][3] - Shandong Dongxiao Biotechnology Co., Ltd. is emerging as a key player in the biotechnology sector in China, leveraging advanced corn processing technology and automation [1][3] Industry Overview - The shift towards "sugar reduction" in the food industry is supported by biotechnology, with natural sweeteners like erythritol redefining "healthy sweetness" [1] - Erythritol is recognized for its natural and safe properties, being the only natural sweetener with no daily intake limit recognized by international authorities [5][6] - The company has established partnerships with major brands such as Yuanqi Forest, Coca-Cola, Nestlé, and Unilever, highlighting its strong market position [6] Company Operations - Dongxiao Biotechnology utilizes a complete value chain from raw material to high-value products, processing corn into various products including starch sugars and amino acids [3] - The company has a robust R&D team of nearly 200 members, focusing on continuous innovation and optimization of fermentation processes to enhance production efficiency [7] - The company has achieved significant improvements in production, including a 5% increase in conversion rate and a 30% reduction in energy consumption through advanced membrane technology [7] Future Developments - Dongxiao Biotechnology is positioning itself for the next generation of natural sweeteners, specifically allulose, which has a sweetness level similar to sucrose but only 10% of its calories [9] - The company aims to expand its product offerings in functional products, including prebiotics, functional amino acids, rare functional sugars, and biodegradable materials [9] - The ongoing innovation in research, manufacturing, and supply chain integration reflects the company's commitment to contributing to the global health trend [9]